NCT03085836View on ClinicalTrials.gov

A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 19, 2017

Primary Completion Date

August 17, 2017

Study Completion Date

August 17, 2017

Conditions
Healthy Participants
Interventions
DRUG

TAK-438

TAK-438 tablets.

Trial Locations (1)

200032

Zhongshan Hospital Fudan University, Shanghai

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY